Overview
Dr. Richard E. Chaisson is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in epidemiology and in international health, both in the Johns Hopkins Bloomberg School of Public Health. His area of clinical expertise is infectious diseases, particularly tuberculosis and HIV/AIDS. Dr. Chaisson serves as the director of the Johns Hopkins University Center for Tuberculosis Research, and is the director of the Johns Hopkins Center for AIDS Research. He received his B.S. and M.D. degrees from the University of Massachusetts. He was an intern, resident, fellow and assistant professor of medicine at the University of California, San Francisco, prior to moving to Johns Hopkins. From 1988 to 1998 he was director of the Johns Hopkins AIDS Service, leading the inpatient Polk Service on Osler 8, a subacute care unit at Bayview Medical Center, and the outpatient Moore Clinic. His cohort studies of HIV and with his colleague Richard Moore made major contributions to understanding the treatment and outcomes of HIV disease. In 1991 he was appointed Medical Director of the Baltimore City Health Department Tuberculosis Clinic, establishing it as a leading program in TB control. He founded the Center for TB Research in 1998, which is one of the world's leading academic center for basic, clinical, applied, and epidemiologic investigations in TB and its control. Dr. Chaisson has conducted multiple trials of treatments and strategies to treat, prevent, and control TB, TB/HIV co-infection, and HIV. From 2002-2014 he led the Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE), and from 2011-2018 he was inaugural chair of the TB Transformative Science Group of the AIDS Clinical Trials Group. In 2022 he was awarded a $200 million cooperative agreement from USAID for SMART4TB, an international research consortium to study tools to end TB globally, working with partners from multiple institutions to implement research, strengthen local capacity, and drive policy change. Dr. Chaisson has been recognized with numerous honors, including the HIV/AIDS Warrior Award from AIDS Action Baltimore in 2022, a Lifetime Achievement Award from the International Union Against TB and Lung Disease North American Region in 2021, election to the Association of American Professors in 2016, the Champions of TB Control Award from the U.S. Agency for International Development (USAID) in 2014 and the American Thoracic Society's World Lung Health Award in 2006.
Dr. Chaisson is highly rated in 1 condition, according to our data. His top areas of expertise are HIV/AIDS, Severe Acute Respiratory Syndrome (SARS), and Sepsis.
His clinical research consists of co-authoring 196 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Graduate Year
Residency
Specialties
Licenses
Board Certifications
Fellowships
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1800 Orleans Street, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Johns Hopkins Hospital
Dr. Anna Durbin is an associate professor at the Johns Hopkins University School of Medicine. Her area of clinical expertise is infectious disease. Dr. Durbin earned her M.D. from Wayne State University School of Medicine. She completed her residency and performed a fellowship in infectious diseases at Detroit Medical Center. She has expertise in the evaluation of live attenuated flavivirus vaccines, primary dengue and West Nile virus vaccines, and the early evaluation of malaria vaccines. She has served on national and international advisory boards and committees related to dengue and malaria vaccine safety. An important research interest of hers is studying the immunopathogenesis of dengue infection and disease. In addition to her clinical studies, her laboratory is also developing an animal model of dengue using rhesus macaques. Dr. Durbin is highly rated in 11 conditions, according to our data. Her top areas of expertise are Dengue Fever, Viral Hemorrhagic Fever, Arbovirosis, and Yellow Fever.
The Johns Hopkins Hospital
Dr. Richard Moore is recognized for mentorship of medical students, residents, fellows, and junior faculty in HIV/AIDS Research. Winner of the David M. Levine Mentorship Awards in the General Internal Medicine Department, he is an expert in pharmacoepidemiology, clinical epidemiology, and health services research. Now serving as the Director of the Moore Clinic for HIV Care, which began in 1984, he has influenced the careers of young scholars not only in General Internal Medicine, but also in the Infectious Disease Division. His colleagues and mentees praise him for his accessibility, his patience, his scientific candor, his instinct for compelling research, his insight, and his abilities as a teacher and editor. Dr. Moore has authored 129 original manuscripts, 24 chapters, reviews and letters. For his medical degree he attended Vanderbilt University School of Medicine where he also completed his Internship and Residency in the Department of Medicine. A fellowship, completed at Johns Hopkins University, Department of Medicine, Division of Internal Medicine, was followed by a Masters of Health Sciences at the Johns Hopkins University, Bloomberg School of Public Health, Department of Epidemiology. Dr. Moore is highly rated in 14 conditions, according to our data. His top areas of expertise are HIV/AIDS, Sepsis, Hepatitis C, Hepatitis, and Gastrostomy.
The Johns Hopkins Hospital
Dr. Kelly Gebo is a graduate of The Johns Hopkins University School of Medicine. She also earned an MPH in Epidemiology from The Johns Hopkins Bloomberg School of Public Health. She completed residency training in Internal Medicine at The Johns Hopkins Hospital followed by an infectious diseases fellowship and two additional years of fellowship training as a Robert Wood Johnson Clinical Scholar, also at Hopkins. Her clinical and research interests include clinical outcomes and healthcare utilization research within infectious diseases. She was Director of the JHU Public Health Studies Program between the Krieger School for Arts and Sciences and the Bloomberg School for Public Health, was an American Council of Education Fellow (hosted at the University of Pennsylvania) and was the inaugural Vice Provost for Education at Johns Hopkins. She was on sabbatical at Stanford University School of Medicine 2019-20 and served as the Chief Medical and Scientific Officer for the All of Us Research Program 2018-2020. She currently serves as the director of the Johns Hopkins Clinical Research Scholars Program and is Deputy Director of the Johns Hopkins Institute for Clinical and Translational Research. She has mentored undergraduate, public health and medical students, trainees, and junior faculty on infectious diseases and health services projects. She has authored or co-authored numerous chapters and over 250 papers. She is a member of the American Society of Clinical Investigation and has been awarded the David Levine Prize for mentoring at Johns Hopkins. LinkedIn https://www.linkedin.com/in/kelly-gebo-13377811/. Dr. Gebo is highly rated in 12 conditions, according to our data. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.
Frequently Asked Questions about Dr. Richard E. Chaisson
How do I make an appointment with Dr. Richard E. Chaisson?
You can book an appointment with Dr. Richard E. Chaisson by calling their office at 410-955-5000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Richard E. Chaisson a top-rated expert for HIV/AIDS?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Richard E. Chaisson is classified as an Distinguished expert for HIV/AIDS, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Richard E. Chaisson specialize in?
While Dr. Richard E. Chaisson is a Infectious Disease, they have specific expertise in HIV/AIDS, Severe Acute Respiratory Syndrome (SARS), and Sepsis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Infectious Disease.
Does Dr. Richard E. Chaisson participate in research or clinical trials?
Yes. Dr. Richard E. Chaisson has published 196 articles and abstracts on conditions like HIV/AIDS. You can view a list of Dr. Richard E. Chaisson's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Richard E. Chaisson accept my insurance?
Dr. Richard E. Chaisson accepts most major insurance plans, including Aetna and CareFirst. We recommend calling the office directly at 410-955-5000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- HIV/AIDSDr. Chaisson isDistinguished. Learn about HIV/AIDS.
- Experienced
- SepsisDr. Chaisson isExperienced. Learn about Sepsis.
- Severe Acute Respiratory Syndrome (SARS)Dr. Chaisson isExperienced. Learn about Severe Acute Respiratory Syndrome (SARS).